Headline News about Global Blood Ther
Via Benzinga
Exposures
Product Safety
Via Benzinga
Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease Drug
May 06, 2021
Via Benzinga
Topics
Earnings
Exposures
Financial
Via Benzinga
Exposures
Product Safety
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.